MPMNs have a prevalence of 0.07 to 13.8% at autopsy or surgical resection, but these lesions are rarely pathologically confirmed by transbronchial lung biopsy (
2-
5). To our knowledge, only two cases of single MPMN have been described in a transbronchial biopsy specimen (
1,
10). The clinicopathologic significance of MPMNs is unclear due to the small numbers of reported studies. Multiple lesions are defined as diffuse pulmonary meningotheliomatosis or MPMN - omatosis (
11). There were no significant differences found between single and multiple MPMN(s) in regards to age, sex, or location; however, there were in regards to nodule size. Each MPMN was significantly larger in multiple MPMN cases than in single MPMN cases (
8).
The etiology of the disease is unknown. MPMNs occur most frequently in the sixth decade and predominantly in women (
3,
8). The lesions are most often found in the upper lobe and right lung (
3,
12). Diameters range from 100 µm to 3 mm.
MPMNs have been associated with various pulmonary abnormalities such as pulmonary thromboembolism, respiratory bronchiolitis - associated interstitial lung disease, desquamative interstitial pneumonia, and atypical adenomatous hyperplasia (
6,
12). Additionally, association with congestive heart failure (
7,
8,
12) or pulmonary neoplasm such as adenocarcinoma has been suggested (
2,
4,
8).
CT findings of MPMNs describe them as a single small nodule, micronodules, and multiple small nodules. Multiple nodules can mimic pulmonary metastasis in a patient with underlying malignancy. Some cavitary changes or central lucency of multiple nodules have been reported in rare cases of the disease (
1,
2). Other uncommon findings of MPMNs are ground glass opacities. Kuroki et al. suggested that this pathophysiology likely resulted from spread of the lesion along the alveolar walls (
9).
To our knowledge, a pattern of peribronchial consolidations containing patent air bronchogram of MPMN has never been described in the English research so far. There are many differential diagnoses for multiple peribronchial consolidations containing patent air bronchogram including both of benign lesions, such as multifocal bronchopneumonias or cryptogenic organizing pneumonias, and pneumonic malignant lesions, such as primary pulmonary adenocarcinomas or pulmonary lymphomas (
13). Adenocarcinoma lineage, especially epidermal growth factor receptor (EGFR) -mutation- positive adenocarcinomas commonly show patent air bronchogram with lepidic growth spreading along the alveolar wall (
14). Therefore, in patients with lung cancer including EGFR - mutation - positive lung cancer, MPMNs should be excluded for the final diagnosis of lung to lung metastases regardless of imaging findings indicating multiple small nodules or multiple peribronchial consolidations.
Patients with MPMNs are usually asymptomatic (
3). However, the patient in this report was symptomatic and she complained of dyspnea. We presumed this symptom was related to atypical extensive peribronchial involvement of MPMNs that were presented as multiple peribronchial consolidations, rather than multiple small nodules. As a result, the term of MPMN is not appropriate in this case, but rather “diffuse pulmonary meningotheliomatosis” is more correct.
In conclusion, MPMNs should be considered in the differential diagnosis of peribronchial consolidations with patent air bronchogram to prevent potential diagnostic pitfall. For the same reason, they should also be considered in the imaging findings suggestive of pneumonic type lung malignancies after excluding pneumonia, particularly when the possibility of malignancy is weak with low fluorodeoxyglucose (FDG) uptake and normal tumor markers.